BioSpace News Archive

Business

Rebeca Sanchez Sarmiento Joins Insightful Science and Dotmatics as Chief Financial Officer

Appointment brings extensive financial industry experience to drive global growth and build corporate value of newly combined organization that is aiming to make the world a healthier, cleaner and better place to live.

November 17, 2021
·
3 min read
Business

Provention Bio Appoints Jan Hillson, M.D., as Senior Vice President of Clinical Development

Provention Bio, Inc. today announced the appointment of Jan Hillson , M.D., as Senior Vice President of Clinical Development.

November 17, 2021
·
5 min read
Business

Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer

Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets, today announced that Marguerite Hutchinson, J.D., has been appointed as the company’s chief business officer.

November 17, 2021
·
2 min read
Business

Fulcrum Therapeutics® Appoints Sonja L. Banks to its Board of Directors

Fulcrum Therapeutics, Inc. today announced the appointment of Sonja L. Banks to the company’s board of directors, effective December 8.

November 17, 2021
·
5 min read
Biotech Bay

Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the successful formulation of a COVID-19 vaccine candidate, obtained from a vaccine developer, utilizing Zosano’s microneedle patch system.

November 17, 2021
·
4 min read
Business

Jaguar Health Reports 2021 Third Quarter Financial Results

Jaguar Health, Inc. today reported consolidated third quarter 2021 financial results.

November 17, 2021
·
17 min read
Genetown

La Jolla Pharmaceutical Company Announces Share Repurchase Plan - Nov 17, 2021

La Jolla Pharmaceutical Company announced that it will commence a share repurchase plan for up to $10 million of the Company’s common stock.

November 17, 2021
·
1 min read
Drug Development

Graphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell Disease

Graphite Bio, Inc. today announced that the first patient has been enrolled in the company’s Phase 1/2 clinical trial of GPH101, an investigational gene-edited autologous hematopoietic stem cell therapy designed to directly correct the genetic mutation that causes sickle cell disease (SCD).

November 17, 2021
·
6 min read
Biotech Beach

Boundless Bio to Present at the Piper Sandler 33rd Annual Healthcare Conference and the Evercore ISI 4th Annual HealthCONx Conference

Boundless Bio to Present at the Piper Sandler 33rd Annual Healthcare Conference and the Evercore ISI 4th Annual HealthCONx Conference.

November 17, 2021
·
1 min read
Business

Abintus Bio Enters Technology Agreement to Enhance In Vivo-Reprogrammed CAR Cell Potency and Durability Against Hematologic Malignancies and Solid Tumors

Abintus Bio, Inc. today announced that it has entered into an agreement with Memorial Sloan Kettering Cancer Center for the use of its next generation signaling technology (“1XX”) in Abintus’ In Vivo CAR-X products.

November 17, 2021
·
4 min read